The report rates Tilaknagar Industries BUY with a target of Rs 700 (45% upside) and highlights its Mansion House brandy brand as best placed to benefit from Tamil Nadu's market opening.
Read this note →Tilaknagar Industries Limited
NSE TI BSE 507205 INE133E01013
0 filings · 0 analysed
484.65
+7.30%
over 5 years
-
The report rates Tilaknagar Industries BUY with a target of Rs 700 (45% upside) and highlights its Mansion House brandy brand as best placed to benefit from Tamil Nadu's market opening.
-
The report maintains a BUY rating with a Sep-27 target price of INR700, citing strengthening execution and festive-season H2FY27 momentum despite a marginal Q2 miss where revenue grew 1% QoQ while EBITDA and earnings declined 2% and 30% respectively due to higher Ind-AS linked interest charges.
-
Tilaknagar Inds Update Oct26 HSIE
The report maintains a BUY rating with a Sep-27 target price of INR700 on 35x P/E, citing management's focus on strengthening the Imperial Blue franchise, premiumization efforts, improving leverage, and potential catalysts from Telangana price hikes and Tamil Nadu market opening.
-
Alcobev Q2FY27 Results Preview HSIE
The report says consolidated revenue could rise ~167% YoY on the acquired Imperial Blue portfolio, but adjusted EBITDA margin may contract ~90bps to 14.2% and adjusted PAT decline 9% YoY to INR482mn due to interest costs of about INR650mn.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 01 Oct 2026, 16:21 | long | 542.55 | 700.00 | 485.50 | -36% | open by 2027-10-01 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report maintains a BUY rating with a Sep-27 target price of INR700, citing strengthening execution and festive-season H2FY27 momentum despite a marginal Q2 miss where revenue grew 1% QoQ while EBITDA and earnings declined 2% and 30% respectively due to higher Ind-AS linked interest charges.
Read this note →The report maintains a BUY rating with a Sep-27 target price of INR700 on 35x P/E, citing management's focus on strengthening the Imperial Blue franchise, premiumization efforts, improving leverage, and potential catalysts from Telangana price hikes and Tamil Nadu market opening.
Read this note →The report says consolidated revenue could rise ~167% YoY on the acquired Imperial Blue portfolio, but adjusted EBITDA margin may contract ~90bps to 14.2% and adjusted PAT decline 9% YoY to INR482mn due to interest costs of about INR650mn.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief